Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301834
Status:
COMPLETED
Last Update Posted:
2017-09-28
First Post:
2006-03-09
Brief Title:
Alemtuzumab Fludarabine and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Severe Congenital Neutropenia |
| Congenital Amegakaryocytic Thrombocytopenia |
| Diamond-blackfan Anemia |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| childhood acute myeloid leukemia in remission | View |
| childhood chronic myelogenous leukemia | View |
| congenital amegakaryocytic thrombocytopenia | View |
| Diamond-Blackfan anemia | View |
| severe congenital neutropenia | View |
| secondary acute myeloid leukemia | View |
| chronic phase chronic myelogenous leukemia | View |
| childhood myelodysplastic syndromes | View |